Brain Aneurysm Patent Case Nearly Set For Trial
The university, which had accused MTI and its subsidiary Dendron GmbH of infringing 12 patents related to the treatment of brain aneurysms, had moved for summary judgment on infringement grounds. MTI had moved for summary judgment on invalidity grounds.
Over the last few months, Judge James Ware of the U.S. District Court...
To view the full article, register now.